diabetes; cancer; obesity; weightloss; glp1

We hosted a Virtual Science Writers Conference to address the surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Society experts discussed the importance of prescribing FDA-approved medications to...

In this episode, Dr. Diane Reidy-Lagunes sits down with MSK’s Dr. Neil Iyengar, a nationally recognized expert on the relationship between obesity, metabolic health, and cancer. Together, they discuss the intriguing connection between a new class of weight loss drugs, called GLP-1 agonists, and...